| |
Publications
Chandak PG, Radovic B, Aflaki E, Kolb D, Buchebner M, Frohlich E, Magnes C, Sinner F, Haemmerle G, Zechner R, Tabas I, Levak-Frank S and Kratky D.
2010. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J Biol Chem, 285:20192-20201.
[pdf]
Buchebner M, Pfeifer T, Rathke N, Chandak PG, Lass A, Schreiber R, Kratzer A, Zimmermann R, Sattler W, Koefeler H, Froehlich E, Kostner GM,
Birner-Gruenberger R, Chiang KP, Haemmerle G, Zechner R, Levak-Frank S, Cravatt BF and Kratky D. 2010. Cholesteryl ester hydrolase activity
is abolished in HSL-/- macrophages but unchanged in macrophages lacking KIAA1363. J Lipid Res, 51:2896-2908.
[pdf]
Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H,
Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, and Kratky D. 2009. Synthetic LXR agonist attenuates plaque
formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res, 50:312-326.
[pdf]
Anandharajan, R; Sayyed, SG; Doshi, LS; Dixit, P; Chandak, PG; Dixit, AV; Brahma, MK; Deshmukh, NJ; Gupte, R; Damre, A; Suthar, J; Padigaru, M; Sharma, SD; Nemmani, KV 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Metabolism. 2009; 58(10): 1503-1516
Chandak, PG; Gaikwad, AB; Tikoo, K Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP.
Phytother Res. 2009; 23(1):72-77
Doshi, LS; Brahma, MK; Sayyed, SG; Dixit, AV; Chandak, PG; Pamidiboina, V; Motiwala, HF; Sharma, SD; Nemmani, KV Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat.
Metabolism. 2009; 58(3): 333-343.
|
